Vera Therapeutics, Inc. (VERA) stock
VERANasdaqPharmaceutical PreparationsFiscal year ends December 31
$28.10−0.94 (-3.24%)
Close on Nov 13, 2026Market cap $2.02BP/E –Yield –
Vera Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vera Therapeutics's enterprise value was $1.58B on Nov 11, 2026, against $1.63B a year earlier. Over the last 5 years it ranged from $52.41M to $2.69B, with a median of $788.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.58B | -41.3% |
| 2025 | Dec 31, 2025 | $2.69B | +48.4% |
| 2024 | Dec 31, 2024 | $1.81B | +319.8% |
| 2023 | Dec 29, 2023 | $432.30M | +17.3% |
| 2022 | Dec 30, 2022 | $368.48M | +182.7% |
| 2021 | Dec 31, 2021 | $130.36M | – |
See a number that looks wrong?